The 3rd Annual Blood-Brain Barrier Summit Returns in August 2021
pharmaphorum
APRIL 29, 2021
This Hanson Wade event is aimed at experts looking to deliver CNS drug candidates safely and successfully across the blood-brain barrier (BBB). It will enable them understand the biology of the BBB, explore the latest technological innovations and develop more predictive preclinical models. An Industry-focused Meeting.
Let's personalize your content